Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingpu Zhang

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 21, 2025
Lipid-Driven OLR1/FOXM1/FGF19 Axis Orchestrates Crosstalk in an Epithelial-Fibroblast Positive Feedback Promoting Progesterone Resistance in Endometrial CancerXingchen Li, Yue Qi, Yuman Wu, et al.
Cancer Letters|July 25, 2025
YY1-glycolytic axis promotes high glucose-induced cancer stemness in endometrial cancer: A multi-omics guided therapeutic strategyXiao Yang, Chengcheng Li, Yuan Cheng, et al.
Nanoscale Advances|September 14, 2023
Regulating the surface topography of CpG nanoadjuvants <i>via</i> coordination-driven self-assembly for enhanced tumor immunotherapyLi Zhang, Lingpu Zhang, Yuqi Wang, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 14, 2023
Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD-L1 for Enhanced Cancer ImmunotherapyBoda Guo, Feiya Yang, Lingpu Zhang, et al.
Molecular Cancer|February 10, 2026
STING-Activating nanoplatforms for image-guided sonodynamic cancer therapyLingpu Zhang, Delong Huang, Jia Li, et al.
Biomaterials|January 12, 2025
Nano-polymeric platinum activates PAR2 gene editing to suppress tumor metastasisYuhong Jiang, Yuke Li, Dongmei Zheng, et al.
Science Advances|March 27, 2021
Exploiting the acquired vulnerability of cisplatin-resistant tumors with a hypoxia-amplifying DNA repair-inhibiting (HYDRI) nanomedicineJing Chen, Xue Wang, Yuan Yuan, et al.
Journal of Nanobiotechnology|June 6, 2022
Abplatin<sup>(IV)</sup> inhibited tumor growth on a patient derived cancer model of hepatocellular carcinoma and its comparative multi-omics study with cisplatinXing Li, Lingpu Zhang, Tuo Li, et al.
Bioactive Materials|April 20, 2026
Manganese-potentiated cGAS-STING activation with ATM/PRMT5 inhibition remodels the immunosuppressive microenvironment in osteosarcoma <i>via</i> bone-targeted deliveryZhaochen Tong, Yuezhan Li, Lingpu Zhang, et al.
Advanced Healthcare Materials|October 13, 2024
Targeting Hypoxia and Autophagy Inhibition via Delivering Sonodynamic Nanoparticles With HIF-2α Inhibitor for Enhancing Immunotherapy in Renal Cell CarcinomaYihao Zhu, Yajian Li, Xuwen Li, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 21, 2025
Lipid-Driven OLR1/FOXM1/FGF19 Axis Orchestrates Crosstalk in an Epithelial-Fibroblast Positive Feedback Promoting Progesterone Resistance in Endometrial CancerXingchen Li, Yue Qi, Yuman Wu, et al.
Cancer Letters|July 25, 2025
YY1-glycolytic axis promotes high glucose-induced cancer stemness in endometrial cancer: A multi-omics guided therapeutic strategyXiao Yang, Chengcheng Li, Yuan Cheng, et al.
Nanoscale Advances|September 14, 2023
Regulating the surface topography of CpG nanoadjuvants <i>via</i> coordination-driven self-assembly for enhanced tumor immunotherapyLi Zhang, Lingpu Zhang, Yuqi Wang, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 14, 2023
Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD-L1 for Enhanced Cancer ImmunotherapyBoda Guo, Feiya Yang, Lingpu Zhang, et al.
Molecular Cancer|February 10, 2026
STING-Activating nanoplatforms for image-guided sonodynamic cancer therapyLingpu Zhang, Delong Huang, Jia Li, et al.
Biomaterials|January 12, 2025
Nano-polymeric platinum activates PAR2 gene editing to suppress tumor metastasisYuhong Jiang, Yuke Li, Dongmei Zheng, et al.
Science Advances|March 27, 2021
Exploiting the acquired vulnerability of cisplatin-resistant tumors with a hypoxia-amplifying DNA repair-inhibiting (HYDRI) nanomedicineJing Chen, Xue Wang, Yuan Yuan, et al.
Journal of Nanobiotechnology|June 6, 2022
Abplatin<sup>(IV)</sup> inhibited tumor growth on a patient derived cancer model of hepatocellular carcinoma and its comparative multi-omics study with cisplatinXing Li, Lingpu Zhang, Tuo Li, et al.
Bioactive Materials|April 20, 2026
Manganese-potentiated cGAS-STING activation with ATM/PRMT5 inhibition remodels the immunosuppressive microenvironment in osteosarcoma <i>via</i> bone-targeted deliveryZhaochen Tong, Yuezhan Li, Lingpu Zhang, et al.
Advanced Healthcare Materials|October 13, 2024
Targeting Hypoxia and Autophagy Inhibition via Delivering Sonodynamic Nanoparticles With HIF-2α Inhibitor for Enhancing Immunotherapy in Renal Cell CarcinomaYihao Zhu, Yajian Li, Xuwen Li, et al.
Pageof 4